New drug combo tested for Tough-to-Treat colon cancer
Disease control
Recruiting now
This study is testing whether adding an experimental drug called leronlimab to standard chemotherapy can help control advanced colorectal cancer that has stopped responding to other treatments. It will involve about 60 adults with a specific type of cancer that has spread and tes…
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC